
Published On: Sep 2020
Published On: Sep 2020
Therapeutics Segment Held Largest Share of Pulmonary Devices Market in 2019
According to our new market research study on"Europe Pulmonary Devices Market to 2027 – Regional Analysis and Forecast by Type, Application and End User" the market is expected to reach US$ 11,398.02 million by 2027 from US$ 5,459.48 million in 2019; it is estimated to grow at a CAGR of 9.7% from 2020 to 2027. The report provides trends prevailing in the Europe pulmonary devices market and the factors driving the market growth along with those hindering it.
In 2019, the therapeutic devices held the largest share in the market and are forecasted to retain its dominance till 2027. The multi-modal and multi-functional use of therapeutic devices for a wide range of pulmonary diseases is expected to account for the growth of the therapeutic de vices segment over the coming years. On the other hand, consumables and accessories is expected to witness fastest growth rate owing to the increasing trend for stockpiling of facial disposable masks to avoid viral transmission.
The growth of the Europe pulmonary devices market is mainly attributed as increasing incidence of respiratory diseases and growing number of COVID-19 patients in the country. However, the unfavorable reimbursement scenario associated with the pulmonary devices is the major factor hindering the market growth in Europe.
Medtronic; Dragerwerk AG & Co. KGaA; Air Liquide; Getinge AB.; Koninklijke Philips N.V. and Hamilton Medical are among the leading companies operating in the Europe pulmonary devices market.
The Report Segments Europe Pulmonary devices Market as Follows:
Europe Pulmonary devices Market – By Type
Europe Pulmonary devices Market – By Application
Europe Pulmonary devices Market – By End User
Europe Pulmonary devices Market – By Country